Simin Chen- 1Department of Clinical Laboratory, Yiyang Central Hospital, Yiyang, Hunan, China
- 2School of Xiangya Basic Medical Science, Central South University, Changsha, Hunan, China
A Corrigendum on
CircMIB1 inhibits glioma development and progression through a competing endogenous RNA interaction network
by Chen S, Li L, Xu W, Xie N, Xu H, Zhou Y, Zou Y, Yi K and Zhang Z (2024). Front. Mol. Biosci. 11:1513919. doi: 10.3389/fmolb.2024.1513919
In the published article, there was an error in the Author list. Corresponding author Zuping Zhang was erroneously excluded and author Yi Liu was erroneously included. The corrected Author list appears below. The correspondence section has been updated accordingly.
Simin Chen1†, Longping Li1†, Wei Xu1, Nanjiao Xie1, Huiting Xu1, Yongjun Zhou1, Ying Zou1, Kai Yi1, Zuping Zhang2*
In the published article, there was an error in Affiliation 2. Instead of “Department of Emergency Medicine and Laboratory of Emergency Medicine, West China Hospital, West China School of Medicine, Sichuan University Chengdu, Chengdu, China”, it should be “School of Xiangya Basic Medical Science, Central South University, Changsha, Hunan, China”.
In the published article, there was an error in the Author contributions. The updated statement appears below:
AUTHOR CONTRIBUTIONS
SC: Funding acquisition, Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Supervision, Visualization, Writing – original draft, Writing – review and editing. LL: Resources, Formal Analysis, Methodology, Visualization, Writing – original draft, Writing – review and editing. WX: Software, Investigation, Methodology, Writing – original draft. NX: Software, Investigation, Writing – original draft. HX: Software, Investigation, Writing – review and editing. YoZ: Investigation, Writing – review and editing. YiZ: Software, Writing – review and editing. KY: Software, Writing – review and editing. ZZ: Resources, Investigation, Funding acquisition, Supervision, Conceptualization, Writing – review and editing.
In the published article, there was an error in the Fundingstatement. Due to an oversight on the part of the first author, the name of funder does not correspond to the official one. The correct Fundingstatement appears below.
FUNDING
The author(s) declare that financial support was received for the research and/or publication of this article. Our research was supported by Hunan Provincial Natural Science Foundation of China (No. 2024JJ9575).
The authors apologize for these errors and state that these do not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: CircMIB1, glioma, MiR-1290, ceRNA, prognostic, biomarker
Citation: Chen S, Li L, Xu W, Xie N, Xu H, Zhou Y, Zou Y, Yi K and Zhang Z (2025) Corrigendum: CircMIB1 inhibits glioma development and progression through a competing endogenous RNA interaction network. Front. Mol. Biosci. 12:1599157. doi: 10.3389/fmolb.2025.1599157
Received: 31 March 2025; Accepted: 31 March 2025;
Published: 16 April 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Chen, Li, Xu, Xie, Xu, Zhou, Zou, Yi and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Zuping Zhang, zhangzuping@csu.edu.cn
†These authors have contributed equally to this work